Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosis

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Cystic Fibrosis (CF)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sir Peter Mansfield Imaging Centre, Nottingham, United Kingdom
Contact: Study coordinator (Mahbuba Amhed) · Mahbuba.Ahmed@nottingham.ac.uk · 0115 95 14747

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF

Cystic Fibrosis

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Tucson, United States

Study With Phage for CF Subjects With Pseudomonas Lung Infection

Chronic Pseudomonas Aeruginosa Infection · Cystic Fibrosis (CF)

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Anchorage, United States

Regional Monitoring of CF Lung Disease

Cystic Fibrosis

Abroad (travel likely)RecruitingEARLY_PHASE1

Cincinnati, United States

Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.

Cystic Fibrosis (CF)

Abroad (travel likely)RecruitingPHASE1

Brisbane, Australia · Melbourne, Australia